UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): June 7, 2010
INVERNESS MEDICAL INNOVATIONS, INC.
(Exact name of registrant as specified in its charter)
         
Delaware   1-16789   04-3565120
         
(State or other jurisdiction of   (Commission File Number)   (IRS Employer
incorporation)       Identification No.)
51 Sawyer Road, Suite 200
Waltham, Massachusetts 02453
(Address of principal executive offices, including zip code)
(781) 647-3900
(Registrant’s telephone number, including area code)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
þ      Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o      Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o      Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
o      Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
 
 

 

 

Item 8.01 Other Events.
     On June 7, 2010, Inverness Medical Innovations, Inc. issued a press release announcing that it had further extended its offer to exchange up to $100,000,000 in aggregate principal amount of its 7.875% Senior Notes due 2016 that have been registered under the Securities Act of 1933, as amended, for a like principal amount of its outstanding unregistered 7.875% Senior Notes due 2016, to 5:00 p.m., New York City time, on Friday, June 11, 2010, unless further extended.
     A copy of the press release is attached as Exhibit 99.1 hereto and incorporated herein by reference.
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits.
     
Exhibit No.   Description
 
   
99.1
  Press Release dated June 7, 2010

 

 

SIGNATURES
     Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
         
  INVERNESS MEDICAL INNOVATIONS, INC.
  		 
  By:   /s/ Jay McNamara    
    Jay McNamara   
    Senior Counsel — Corporate & Finance   
Date: June 7, 2010

 

 

EXHIBIT INDEX
     
Exhibit No.   Description
 
   
99.1
  Press Release dated June 7, 2010

 

Alere Inc. Common Stock (NYSE:IMA)
Historical Stock Chart
From Mar 2024 to Apr 2024 Click Here for more Alere Inc. Common Stock Charts.
Alere Inc. Common Stock (NYSE:IMA)
Historical Stock Chart
From Apr 2023 to Apr 2024 Click Here for more Alere Inc. Common Stock Charts.